GSK Gives Up on Rare Diseases as Gene Therapy Gets Two Customers GSK Gives Up on Rare Diseases as Gene Therapy Gets Two Customers

GlaxoSmithKline is swimming against the tide by getting out of treatments for rare diseases at a time when rivals like Sanofi and Shire see the field as a rich seam for profits.Reuters Health Information
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Family Medicine/Primary Care News Source Type: news